Lyka Generics Ltd 's Insider Trades & SAST Disclosures

No reported Insider Trades available for Lyka Generics Ltd in the Trendlyne database.

Lyka Generics Ltd 's has made SAST transactions in Lyka Labs Ltd. recently where a Acquisition of 24,839 shares done . Disclosure was reported to the exchange on Sept. 25, 2023.

Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Lyka Labs
Lyka Generics Ltd & PACs Promoter Acquisition 04 Oct 2023 24,839 5,775,000 (17.45%) 0.07% - 22 Sep 2023
22 Sep 2023
SAST (29(2)) - Market
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST